Pay in 4 interest-free payments of $7.20 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
A Phase 1 Randomized, Double Blind, Placebo Controlled, Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CT-388 in Otherwise Healthy Overweight and Obese Adult Participants and in Obese Patients With Type 2 Diabetes Mellitus [Internet
By losing weight, it makes being more active and exercising more frequently much easier
Patients range in age from 4 to 98 years (mean 43,7), showing predilection for females (1,9:1)
Darien Sutton, Cedars-Sinai Medical Center's Dr
Acta , 2015 , 438 , 307-308
Cyclic adenosine monophosphate critically modulates cardiac GLP-1 receptors anti-inflammatory effects
US$ 26.85
US$ 29.51
US$ 22.87
US$ 23.86
US$ 29.49
